for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

REFILE-Regeneron to not enrol COVID-19 patients in need of ventilators for antibody trial

(Corrects typo in headline)

Oct 30 (Reuters) - Regeneron Pharmaceuticals said on Friday an independent data monitoring panel recommended placing on hold enrolment to its trial for COVID-19 antibody treatment in hospitalized patients requiring high-flow oxygen or mechanical ventilation.

The committee, however, backed the enrolment in non-hospitalized patients as well as hospitalized patients requiring either no or low-flow oxygen. (Reporting by Ankur Banerjee in Bengaluru; Editing by Arun Koyyur)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up